Biosimilars: Complements and Comments on the Recent Statement of the SFR and CRI. Comment On: “biosimilars: an Opportunity. Position Statement of the French Rheumatology Society (SFR) and Inflammatory Rheumatic Disease Club (CRI).” Schaeverbeke Et Al. Joint Bone Spine 2018;95:399-402
Joint Bone Spine（2019）
Key words
Biosimilars,Rheumatology,Extrapolation,Interchanggeability,Shared decision making,Nocebo
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined